| 000 | 01849 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250518083211.0 | ||
| 264 | 0 | _c20200212 | |
| 008 | 202002s 0 0 fre d | ||
| 022 | _a1769-6917 | ||
| 024 | 7 |
_a10.1016/S0007-4551(20)30050-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSebaoun, Perle | |
| 245 | 0 | 0 |
_a[Tolerance of Tamoxifen as an adjuvant therapy and long-term follow up of 55 premenopausal breast cancer women, cared for at the Institut de cancérologie de Lorraine, treated with Tamoxifen]. _h[electronic resource] |
| 260 |
_bBulletin du cancer _cDec 2019 |
||
| 300 |
_aS75-S100 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmenorrhea _xchemically induced |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAromatase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCancer Care Facilities |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 |
_aHot Flashes _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aOvarian Cysts _xchemically induced |
| 650 | 0 | 4 | _aPremenopause |
| 650 | 0 | 4 | _aProgression-Free Survival |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSelective Estrogen Receptor Modulators _xadministration & dosage |
| 650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aFrederic, Marchal | |
| 700 | 1 | _aWeryha, Georges | |
| 700 | 1 | _aHamdaoui, Sara El | |
| 700 | 1 | _aSalleron, Julia | |
| 700 | 1 | _aLesur, Anne | |
| 773 | 0 |
_tBulletin du cancer _gvol. 106 _gno. 12S1 _gp. S75-S100 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0007-4551(20)30050-3 _zAvailable from publisher's website |
| 999 |
_c30586690 _d30586690 |
||